Clinical Trial Update: Neoadjuvant Chemoradiotherapy Combined With PD-1 Antibody in Locally Advanced Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating neoadjuvant chemoradiotherapy combined with a PD-1 antibody in locally advanced esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Tongji Hospital | Conditions: Esophagus Cancer | Phase 2 | Status: UNKNOWN